EN | VI

RegenoGel – A New Biological Solution in the Treatment of Musculoskeletal Disorders

High Prevalence of Musculoskeletal Conditions Among Adults in Vietnam


Data from the healthcare sector indicates that Vietnam ranks among the countries with a high rate of musculoskeletal disorders. Specifically, approximately 30% of people over the age of 35, 60% of those over 65, and up to 85% of individuals over 85 suffer from joint degeneration-related conditions.


Joint problems not only cause prolonged pain but also seriously affect mobility and quality of life, especially among the elderly.


In response to this reality, the healthcare sector is promoting research and the application of supportive treatment solutions to improve patients’ quality of life.

 

Musculoskeletal disorders are increasingly affecting younger individuals

 

Joint Injection Gel – A Popular Conservative Treatment Option


Currently, there is no definitive cure for chronic musculoskeletal conditions, particularly age-related osteoarthritis. Treatment approaches mainly focus on pain relief, maintaining joint function, and slowing disease progression.


Among these, intra-articular injections using gel containing Hyaluronic Acid (HA) are a commonly adopted treatment due to their effectiveness in quickly relieving pain and improving joint function.

 

RegenoGel – A Joint Injection Gel Developed with Advanced Biotechnology


RegenoGel is a product developed by Procore Bio Med (Israel), a biotechnology company specializing in solutions for patients with musculoskeletal disorders.


The product is based on the proprietary HAProLink technology, which combines Hyaluronic Acid with a specific protein to create a favorable environment for cartilage and bone regeneration. RegenoGel has been approved for circulation by the Israeli Ministry of Health since 2016.

 

Features and Benefits of RegenoGel


RegenoGel is a viscous gel injected directly into the joint, offering long-lasting pain relief and supporting the repair of cartilage damaged by arthritis or trauma-induced degeneration.


The product is formulated with a proprietary blend aimed at slowing down degeneration and protecting joints from further damage.

 

RegenoGel helps provide long-lasting joint pain relief

 

RegenoGel’s Unique Mechanism of Action


RegenoGel works in two phases:

  • In the initial phase, it remains in a liquid state, allowing it to easily infiltrate and fill joint lesions.

  • Subsequently, it transforms into an insoluble gel, forming a mechanical cushion that reduces pressure, lubricates the joint, and supports joint function.

 

RegenoGel utilizes high molecular weight HA—a natural component in the body that aids lubrication, elasticity, and inflammation reduction—combined with fibrinogen, a critical protein in tissue regeneration and wound healing.


This combination creates a stable gel system that not only provides mechanical support but also promotes biological healing, helping reduce pain quickly and slow down the progression of joint degeneration.

 

What Sets RegenoGel Apart from Other Intra-Articular Injections


Unlike products containing only pure HA, RegenoGel employs Procore’s proprietary crosslinking technology to form a stable gel immediately after injection. This allows for longer retention within the joint and more sustained effectiveness.


Additionally, RegenoGel not only alleviates pain but also fosters a biologically supportive environment for joint recovery. Its transformation from liquid to gel post-injection makes the procedure smoother and reduces discomfort for patients.

 

RegenoGel promotes the production of endogenous hyaluronic acid (HA)

 

Who Can Use RegenoGel?


RegenoGel is indicated for patients with degenerative joint conditions such as osteoarthritis affecting the knees, hips, shoulders, and ankles.


It is suitable for a wide range of individuals—from athletes with injuries to elderly patients with age-related joint degeneration. The treatment is administered by a specialist and typically requires only one injection, with effects lasting for at least three months.


Note: RegenoGel is a specialized medical product and should only be used under the supervision and prescription of a healthcare professional.

For more information about RegenoGel intra-articular injection gel, please leave your contact details on our website to receive support.